SphygmoCor XCEL Receives Regulatory Approval In Mexico
AtCor Medical has reported that its SphygmoCor XCEL system has been approved by the ComisiÃ³n Federal para la ProtecciÃ³n contra Riesgos Sanitarios (Cofepris) in Mexico. This enables BCR Internacional, AtCor's Mexican distributor, to market and sell the system to clinicians and researchers in Mexico. The company's SphygmoCor system visibly identifies the effects of reflected blood pressure in the central aortic pressure wave, effects which cannot be detected with standard blood pressure monitoring. SphygmoCor XCEL is well positioned to provide this information in a cost effective manner.